FDA Approves At-Home Test For All Known Variants

NBC News reports:

Tens of millions. That’s how many rapid COVID-19 tests Indianapolis-based Roche Diagnostics plans to make, now that they have the green light from the Food and Drug Administration.

The FDA granted emergency use authorization Friday for an at-home COVID-19 test developed by Roche.

The test is for individuals ages 2 and older and can be collected and tested at home via nasal swab, with results in 20 minutes. According to Roche, the test gives results for all COVID-19 variants, including omicron.

Read the full article.

BREAKING: Roche announces it has received emergency use authorization from FDA for its serial at-home Covid-19 test.

The NIH RADx Independent Test Assessment Program helped facilitate the process.

Launching in January w/ capacity of “tens of millions of tests per month.”

— David Lim (@davidalim) December 24, 2021